Taiho Oncology Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TAIHO ONCOLOGY, and when can generic versions of TAIHO ONCOLOGY drugs launch?
TAIHO ONCOLOGY has two approved drugs.
There are nine US patents protecting TAIHO ONCOLOGY drugs.
There are one hundred and sixty-one patent family members on TAIHO ONCOLOGY drugs in thirty-three countries and sixteen supplementary protection certificates in fourteen countries.
Drugs and US Patents for Taiho Oncology
Expired US Patents for Taiho Oncology
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine | TABLET;ORAL | 207981-002 | Sep 22, 2015 | 6,479,500 | ⤷ Try a Trial |
Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine | TABLET;ORAL | 207981-001 | Sep 22, 2015 | 5,744,475 | ⤷ Try a Trial |
Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine | TABLET;ORAL | 207981-002 | Sep 22, 2015 | 5,744,475 | ⤷ Try a Trial |
Taiho Oncology | LONSURF | tipiracil hydrochloride; trifluridine | TABLET;ORAL | 207981-001 | Sep 22, 2015 | 6,479,500 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Taiho Oncology Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2914999 | ⤷ Try a Trial |
Philippines | 12015502809 | ⤷ Try a Trial |
Serbia | 62691 | ⤷ Try a Trial |
Spain | 2946472 | ⤷ Try a Trial |
New Zealand | 750260 | ⤷ Try a Trial |
Slovenia | 3012255 | ⤷ Try a Trial |
Spain | 2630002 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taiho Oncology Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1849470 | 2017/033 | Ireland | ⤷ Try a Trial | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1096 20160425 |
1849470 | 1790063-0 | Sweden | ⤷ Try a Trial | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL HYDROCHLORIDE; REG. NO/DATE: EU/1/16/1096 20160427 |
1849470 | 17C1028 | France | ⤷ Try a Trial | PRODUCT NAME: TRIFLURIDINE/TIPIRACIL; REGISTRATION NO/DATE: EU/1/16/1096 20160427 |
1849470 | PA2017024,C1849470 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: TRIFLURIDINAS/TIPIRACILAS; REGISTRATION NO/DATE: EU/1/16/1096 20160425 |
1849470 | 300889 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TRIFLURIDINE IN COMBINATIE MET TIPIRACILHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1096 20160427 |
2657233 | 301254 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FUTIBATINIB OF EEN ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/23/1741 20230706 |
1849470 | 322 20-2017 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: TRIFLURIDIN/TIPIRACIL VO VSETKYCH FORMACH CHRA- NENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/16/1096 20160427 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.